Table 2.
Medical co-morbidities over time [n (%)]
Diseases | Baseline | Cycle-4 | 1-Year | |||
---|---|---|---|---|---|---|
BC (n=66) | NC (n=55) | BC (n=58) | NC (n=49) | BC (n=41) | NC (n=28) | |
Cardiovascular diseases | 2 (3.0) | 0 (0.0) | 2 (3.5) | 0 (0.0) | 1 (2.4) | 0 (0.0) |
Pulmonary diseases | 0 (0.0) | 0 (0.0) | 1 (1.7) | 0 (0.0) | 1 (2.4) | 0 (0.0) |
Central nervous diseases | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (2.4) | 0 (0.0) |
Gastrointestinal diseases | 4 (6.1) | 0 (0.0) | 2 (3.5) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Renal disease | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Endocrine disease | 5 (7.6) | 0 (0.0) | 1 (1.7) | 2 (4.1) | 0 (0.0) | 1 (3.6) |
Connective tissue diseases | 1 (1.5) | 0 (0.0) | 2 (3.5) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Infections | 3 (4.6) | 0 (0.0) | 2 (3.5) | 2 (4.1) | 2 (4.9) | 1 (3.6) |
Dementia | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Arthritis | 8 (12.2) | 4 (7.3) | 6 (10.3) | 5 (10.2) | 11 (26.8) | 7 (25.0) |
Diabetes | 4 (6.1) | 0 (0.0) | 3 (5.2) | 0 (0.0) | 2 (4.9) | 1 (3.6) |
Ulcer | 2 (3.0) | 0 (0.0) | 1 (1.7) | 0 (0.0) | 1 (2.4) | 0 (0.0) |
Hiatal hernia | 0 (0.0) | 1 (1.8) | 0 (0.0) | 1 (2.4) | 2 (4.9) | 0 (0.0) |
Esophageal diseases | 1 (1.5) | 0 (0.0) | 1 (1.7) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Neck/back/spine problems | 10 (15.2) | 9 (16.4) | 10 (17.2) | 11 (22.5) | 9 (21.9) | 6 (21.4) |
Epilepsy | 0 (0.0) | 0 (0.0) | 1 (1.7) | 0 (0.0) | 1 (2.4) | 0 (0.0) |
Headaches | 12 (18.2) | 6 (10.9) | 15 (25.9) | 5 (10.2) | 12 (29.3) | 6 (21.4) |
High blood pressure | 10 (15.2) | 11 (20.0) | 8 (13.8) | 11 (22.5) | 8 (19.5) | 7 (25.0) |
Kidney problems | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Stroke | 0 (0.0) | 1 (1.8) | 1 (1.7) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Asthma | 6 (9.1) | 3 (5.5) | 6 (10.3) | 4 (8.2) | 3 (7.3) | 1 (3.6) |
Emphysema | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (2.4) | 0 (0.0) |
Edema | 2 (3.0) | 0 (0.0) | 3 (5.2) | 1 (2.4) | 2 (4.9) | 1 (3.6) |
Thyroid disease | 12 (18.2) | 3 (5.5) | 10 (17.2) | 4 (8.2) | 8 (19.5) | 3 (10.7) |
Other diseases | 8 (12.2) | 4 (7.3) | 13 (22.4) | 1 (2.4) | 6 (14.6) | 2 (7.1) |
Note: BC= breast cancer patients, NC= cancer-free controls. Data for 2 BC and 5 NC were not available at Baseline; 8 more BC and 6 more NC at Cycle-4, and 25 more BC and 27 more NC at 1-Year, were either dropped or stopped due to the end of study. There were no significant group differences at Baseline (all p’s>0.5); and no changes over time in both groups for all disease (all p’s>0.06).